Tigilanol Tiglate
1,873 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
1,873
Total Reports
143
Deaths Reported
760.0%
Death Rate
Active Ingredients
Tigilanol Tiglate
Administration Routes
ParenteralOtherUnknownIntralesionalOralIntratumorSubcutaneousOphthalmicIntradermalIntravenous
Species Affected
Dog 1,852
Unknown 7
Human 7
Horse 4
Cat 2
Other 1
Most Affected Breeds
Pit Bull 247
Dog (unknown) 236
Retriever - Labrador 222
Boxer (German Boxer) 147
Retriever - Golden 84
Bulldog - French 78
Chihuahua 71
Terrier - Boston 61
Pug 53
Terrier - Bull - Staffordshire 42
Most Reported Reactions
Lack of efficacy - NOS 854
Injection site swelling 661
Wound 374
Injection site pain 298
Swelling NOS 282
Pain NOS 270
Injection site necrosis 231
Injection site complication NOS 208
Injection site bruising 201
Swollen limb 187
Injection site bleeding 177
Licking at injection site 175
Outcome Breakdown
Outcome Unknown
1,144 (61.3%)
Recovered/Normal
451 (24.2%)
Ongoing
100 (5.4%)
Died
73 (3.9%)
Euthanized
70 (3.8%)
Recovered with Sequela
28 (1.5%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.